Print Page | Contact Us | Sign In | Join WAPA
SGLT-2 Inhibition: A Glucuretic Treatment Option for Your Adult Patients with Type 2 Diabetes
Tell a Friend About This EventTell a Friend
 

 Export to Your Calendar 6/26/2019
When: Wednesday, June 26, 2019
6:30 PM
Where: Braise Restaurant
1101 South 2nd Street
Milwaukee, Wisconsin  53204
United States
Contact: Lisa Welk-Goodings
414-807-0901

« Go to Upcoming Event List  

Please join us
SGLT-2 Inhibition: A Glucuretic Treatment Option for Your Adult Patients with Type 2 Diabetes

Speaker
Maria O'connor, PA-C, RD, CDE
Clinical Science Liason
AZ Medical Affairs, Cardiovascular Metabolic Disease

Place
Braise Restaurant
1101 South 2nd Street
Milwaukee, WI, 53204

Date
June 26, 2019

Time
06:30 PM – 08:00 PM
Central Standard Time

RSVP to
Lisa Welk-Goodings at
414-807-0901 by
6/21/2019


AstraZeneca will comply with any and all federal or state reporting requirements regarding any value or expense associated with this event. AstraZeneca fully supports and abides by the PhRMA Code on interactions with health care professionals (HCPs). This program is open only to HCP invitees. AstraZeneca will not accommodate attendance of a spouse or other guest of any HCP attendee, nor will AstraZeneca pay for transportation or parking costs of attendees.
If you are a prescriber and/or a Federal, State, or institution employee, you may be subject to laws, regulations or rules which prohibit or limit your receipt of gifts, meals or items of value. We ask that you comply with any such restrictions. AstraZeneca will not recommend, endorse, or support the submission of this promotional program for CE credits.